Related Experiment Video
Updated: Aug 16, 2026

The Drosophila Imaginal Disc Tumor Model: Visualization and Quantification of Gene Expression and Tumor Invasiveness Using Genetic Mosaics
Published on: October 6, 2016
Genome-wide RNAi analysis of JAK/STAT signaling components in Drosophila
Gyeong-Hun Baeg1, Rui Zhou, Norbert Perrimon
1Department of Genetics, Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115, USA.
Abstract:
The cytokine-activated Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway plays an important role in the control of a wide variety of biological processes. When misregulated, JAK/STAT signaling is associated with various human diseases, such as immune disorders and tumorigenesis. To gain insights into the mechanisms by which JAK/STAT signaling participates in these diverse biological responses, we carried out a genome-wide RNA interference (RNAi) screen in cultured Drosophila cells. We identified 121 genes whose double-stranded RNA (dsRNA)-mediated knockdowns affected STAT92E activity. Of the 29 positive regulators, 13 are required for the tyrosine phosphorylation of STAT92E. Furthermore, we found that the Drosophila homologs of RanBP3 and RanBP10 are negative regulators of JAK/STAT signaling through their control of nucleocytoplasmic transport of STAT92E. In addition, we identified a key negative regulator of Drosophila JAK/STAT signaling, protein tyrosine phosphatase PTP61F, and showed that it is a transcriptional target of JAK/STAT signaling, thus revealing a novel negative feedback loop. Our study has uncovered many uncharacterized genes required for different steps of the JAK/STAT signaling pathway.
Insights
This study used a genome-wide RNA interference screen in Drosophila to identify genes regulating the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway. Researchers uncovered novel positive and negative regulators, including those involved in STAT phosphorylation and nucleocytoplasmic transport.
Area of Science:
- Cellular Biology
- Genetics
- Molecular Biology
Background:
- The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway is crucial for biological processes.
- Dysregulation of JAK/STAT signaling is linked to diseases like immune disorders and cancer.
Purpose of the Study:
- To identify novel regulators of the JAK/STAT pathway using a genome-wide approach.
- To understand the mechanisms underlying JAK/STAT signaling in various biological responses.
Main Methods:
- Conducted a genome-wide RNA interference (RNAi) screen in cultured Drosophila cells.
- Utilized double-stranded RNA (dsRNA) to knock down gene expression and assess effects on STAT92E activity.
Main Results:
- Identified 121 genes affecting STAT92E activity, including 29 positive regulators.
- Discovered RanBP3 and RanBP10 homologs as negative regulators controlling STAT92E nucleocytoplasmic transport.
- Identified protein tyrosine phosphatase PTP61F as a novel negative regulator and transcriptional target, revealing a feedback loop.
Conclusions:
- Uncovered numerous uncharacterized genes involved in various stages of the JAK/STAT signaling pathway.
- Provided new insights into the complex regulation of JAK/STAT signaling, including its role in nucleocytoplasmic transport and feedback mechanisms.
- Highlighted the utility of Drosophila as a model system for dissecting conserved signaling pathways relevant to human health and disease.
Related Concept Videos
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
MAPK Signaling Cascades

